Hong Seng Consolidated Berhad (KLSE:HONGSENG) - Aktienkurs, Nachrichten und Analyse

HONGSENG Aktienübersicht

Hong Seng Consolidated Berhad, eine Investment-Holdinggesellschaft, ist hauptsächlich in Malaysia in den Bereichen Suche und Werbung, Gesundheitswesen, Finanzdienstleistungen und anderen Bereichen tätig.

Über das Unternehmen

HONGSENG grundlegende Analyse
Schneeflocken-Punktzahl
Bewertung	2/6
Künftiges Wachstum	0/6
Vergangene Leistung	0/6
Finanzielle Gesundheit	5/6
Dividenden	0/6

Belohnungen

91.2% unter unserer Schätzung des beizulegenden Zeitwerts gehandelt

Risikoanalyse

Stark schwankender Aktienkurs in den letzten 3 Monaten

Hat keine nennenswerte Marktkapitalisierung (MYR77M)

Hat keine nennenswerten Einnahmen (MYR15M)

Hong Seng Consolidated Berhad Wettbewerber

Smile-Link Healthcare Global Berhad

KLSE:SMILE

RM 40.4m

DC Healthcare Holdings Berhad

KLSE:DCHCARE

RM 209.2m

Optimax Holdings Berhad

KLSE:OPTIMAX

RM 374.9m

Metro Healthcare Berhad

KLSE:MHCARE

RM 388.5m

Preisentwicklung & Leistung

Übersicht über alle Höchststände, Veränderungen und Kursrückgänge für Hong Seng Consolidated Berhad
Historische Aktienkurse
Aktueller Aktienkurs	RM 0.01
52-Wochen-Hoch	RM 0.10
52-Wochen-Tief	RM 0.005
Beta	1.94
11 Monat Veränderung	-33.33%
3 Monate Veränderung	0%
1 Jahr Veränderung	-88.89%
33 Jahre Veränderung	-97.66%
5 Jahre Veränderung	-80.49%
Veränderung seit IPO	-83.18%

Aktuelle Nachrichten und Updates

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Jun 09

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Oct 12

Recent updates

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Jun 09

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Oct 12

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

May 11

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Jan 27

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Jan 04

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Nov 30

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Oct 26

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Aug 31

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Aug 09

Aktionärsrenditen

	HONGSENG	MY Healthcare	MY Markt
7D	0%	0.5%	-0.9%
1Y	-88.9%	10.5%	19.2%

Rendite im Vergleich zur Industrie: HONGSENG unter dem Niveau der Branche MY Healthcare , die im vergangenen Jahr eine Rendite von 9.3% erzielte.

Rendite vs. Markt: HONGSENG hinter dem Markt MY zurück, der im vergangenen Jahr eine Rendite von 20.7 erzielte.

Preisvolatilität

Is HONGSENG's price volatile compared to industry and market?
HONGSENG volatility
HONGSENG Average Weekly Movement	60.6%
Healthcare Industry Average Movement	4.1%
Market Average Movement	5.6%
10% most volatile stocks in MY Market	11.3%
10% least volatile stocks in MY Market	2.6%

Stabiler Aktienkurs: HONGSENGDer Aktienkurs des Unternehmens war in den letzten 3 Monaten unbeständig.

Volatilität im Zeitverlauf: HONGSENGDie wöchentliche Volatilität der Aktie ist im vergangenen Jahr von 40% auf 58% gestiegen.

Über das Unternehmen

Gegründet	Mitarbeiter	CEO	Website
2001	n/a	n/a	www.hongseng.com.my

Hong Seng Consolidated Berhad, eine Investment-Holdinggesellschaft, ist in den Bereichen Suche und Werbung, Gesundheitswesen, Finanzdienstleistungen und Sonstiges tätig, hauptsächlich in Malaysia. Das Unternehmen ist in den Segmenten Gesundheitswesen, Finanzdienstleistungen, Handschuhe, Suche und Werbung sowie Sonstige tätig. Das Unternehmen bietet medizinische Diagnose- und Forschungslabordienstleistungen, Großhandel mit pharmazeutischen und medizinischen Produkten sowie Geldverleihdienste an.

Hong Seng Consolidated Berhad's Grundlagenzusammenfassung

Wie verhalten sich die Erträge und Einnahmen von Hong Seng Consolidated Berhad im Vergleich zum Marktanteil des Unternehmens?
HONGSENG grundlegende Statistiken
Marktanteil	RM 76.63m
Gewinn(TTM)	-RM 61.96m
Umsatz(TTM)	RM 14.95m

3.4x

Kurs-Umsatz-Verhältnis

-0.8x

Kurs-Gewinn-Verhältnis

Ist HONGSENG zu teuer?

Siehe Fair Value und Bewertungsanalyse

Erträge & Einnahmen

Wichtige Rentabilitätsstatistiken aus dem letzten Ergebnisbericht (TTM)
HONGSENG Gewinn- und Verlustrechnung (TTM)
Einnahmen	RM 14.95m
Kosten der Einnahmen	RM 37.72m
Bruttogewinn	-RM 22.78m
Sonstige Ausgaben	RM 39.18m
Umsatz	-RM 61.96m

Zuletzt gemeldete Gewinne

Mar 31, 2024

Datum des nächsten Gewinnberichts

k.A.

Gewinn per Aktie (EPS)	-0.012
Bruttomarge	-152.36%
Nettogewinnspanne	-414.50%
Schulden/Eigenkapital-Verhältnis	3.8%

Wie hat sich HONGSENG auf lange Sicht entwickelt?

Historische Performance und Vergleiche

HONGSENG Aktienübersicht

Belohnungen

Risikoanalyse

Hong Seng Consolidated Berhad Wettbewerber

KLSE:SMILE

RM 40.4m

KLSE:DCHCARE

RM 209.2m

KLSE:OPTIMAX

RM 374.9m

KLSE:MHCARE

RM 388.5m

Preisentwicklung & Leistung

Aktuelle Nachrichten und Updates

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Less than half of directors are independent

New minor risk - Financial data availability

Hong Seng Consolidated Berhad Announces the Resignation of Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0.004 profit in 3Q 2022)

Recent updates

Health Check: How Prudently Does Hong Seng Consolidated Berhad (KLSE:HONGSENG) Use Debt?

Less than half of directors are independent

New minor risk - Financial data availability

Hong Seng Consolidated Berhad Announces the Resignation of Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) Weighed On By Its Debt Load?

Third quarter 2023 earnings released: RM0.001 loss per share (vs RM0.004 profit in 3Q 2022)

New major risk - Share price stability

Hong Seng Consolidated Berhad Announces Cessation of Teoh Soon Han as Alternate Director

Second quarter 2023 earnings released: RM0.002 loss per share (vs RM0.008 profit in 2Q 2022)

Hong Seng Consolidated Berhad Appoints Loo Hui Yan as Joint Secretary

Is Hong Seng Consolidated Berhad (KLSE:HONGSENG) A Risky Investment?

Hong Seng Consolidated Berhad entered into a Shares Sale Agreement to acquire Alliance EV Sdn Bhd from CSH Alliance Berhad for MYR 20 million.

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.016 in FY 2021)

Hong Seng Consolidated Berhad agreed to acquire 51% stake in Innov8tif Holdings Sdn Bhd from Innov8tif Consortium Sdn Bhd for MYR 30.9 million.

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 27, 2023

We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Can Stay On Top Of Its Debt

Here's Why We Think Hong Seng Consolidated Berhad (KLSE:HONGSENG) Is Well Worth Watching

Investors Shouldn't Be Too Comfortable With Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Robust Earnings

Full year 2022 earnings released: EPS: RM0.019 (vs RM0.013 in FY 2021)

Hong Seng Consolidated Berhad Reports Impairment Charges for the Fourth Quarter Ended September 30, 2022

High number of new and inexperienced directors

Shareholders Would Enjoy A Repeat Of Hong Seng Consolidated Berhad's (KLSE:HONGSENG) Recent Growth In Returns

Hong Seng Consolidated Berhad Appoints Tea Sor Hua as Company Secretary, Effective October 1, 2022

Hong Seng Consolidated Berhad Announces Re-Designation of Tuan Ng Keok Chai from Member of Remuneration Committee to Chairman of Remuneration Committee

Hong Seng Consolidated Berhad Appoints Dato Kang Chez Chiang as Independent and Non Executive Member of Nomination Committee

Hong Seng Consolidated Berhad (KLSE:HONGSENG) Shares May Have Slumped 28% But Getting In Cheap Is Still Unlikely

Hong Seng Consolidated Berhad Reports Plant and Equipment Written Off for the Quarter Ended June 30, 2022

Third quarter 2022 earnings released: EPS: RM0.004 (vs RM0.013 in 3Q 2021)

We Ran A Stock Scan For Earnings Growth And Hong Seng Consolidated Berhad (KLSE:HONGSENG) Passed With Ease

Second quarter 2022 earnings: EPS and revenues miss analyst expectations

Investor sentiment deteriorated over the past week

High number of new and inexperienced directors

Investor sentiment deteriorated over the past week

Full year 2021 earnings: EPS and revenues miss analyst expectations

Hong Seng Consolidated Berhad Appoints Dato Mohamed Suffian Bin Awang as Independent and Non Executive Chairman

Hong Seng Consolidated Berhad, Annual General Meeting, Feb 25, 2022

Second quarter 2022 earnings: Revenues miss analyst expectations

Robust Potential Sdn Bhd entered into an agreement to acquire Hong Seng Priority Management Sdn Bhd from Hong Seng Consolidated Berhad (KLSE:HONGSENG) for MYR 34.5 million.

Senior Independent Non-Executive Director Mun Wong has left the company

Full year 2021 earnings released: EPS RM0.022 (vs RM0.025 loss in FY 2020)

Hong Seng Consolidated Berhad Announces Appointment of Mr. Christopher Chan Hooi Guan as Executive Director

Independent Non Executive Director has left the company

Hong Seng Consolidated Berhad Resigns Ym Tengku Farith Rithauddeen as Independent and Non Executive Independent Director

Hong Seng Consolidated Berhad Resigns Tengku Farith Rithauddeen as Independent and Non Executive Chairman of Nomination Committee

Third quarter 2021 earnings released: EPS RM0.006 (vs RM0.002 loss in 3Q 2020)

Hong Seng Consolidated Berhad Announces Resignation of Mr. Lim Peng Tong as Executive Director

New 90-day high: RM1.35

New 90-day high: RM1.15

Second quarter 2021 earnings released: EPS RM0.003

New 90-day low: RM0.99

Hong Seng Consolidated Berhad (KLSE:HONGSENG) entered into a share sale agreement to acquire remaining 49% stake in HS Bio Supplies Sdn Bhd from United ICT Consortium Sdn. Bhd. For MYR 0.98 million.

MSCM Holdings Berhad Announces Cessation of Wong Yee Ming as Non-Independent and Non-Executive Alternate Director

First quarter earnings released

New 90-day high - RM1.50

Landasan Simfoni Sdn Bhd entered into a share sale agreement to acquire 47.19% sake in MSCM Holdings Berhad (KLSE:MYSCM) from MMag Holdings Berhad (KLSE:MMAG) for MYR 0.75 million.

New 90-day high - RM0.20

Aktionärsrenditen

Preisvolatilität

Über das Unternehmen

Erträge & Einnahmen